about
Virulence factors of medically important fungiInvasive Aspergillus Sinusitis in Human Immunodeficiency Virus Infection: Case Report and Review of the LiteratureIn vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and CandidaEfficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary Aspergillosis in neutropenic mice.Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeastsIn vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens.Pulmonary aspergillosis as opportunistic mycoses in a cohort of human immunodeficiency virus-infected patients: Report from a tertiary care hospital in North India.Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppressionProton-pumping-ATPase-targeted antifungal activity of a novel conjugated styryl ketone.Susceptibility testing of Aspergillus flavus: inoculum dependence with itraconazole and lack of correlation between susceptibility to amphotericin B in vitro and outcome in vivoIn vitro and in vivo antifungal activities of TAK-456, a novel oral triazole with a broad antifungal spectrum.Persistence versus escape: Aspergillus terreus and Aspergillus fumigatus employ different strategies during interactions with macrophages.Th1 and Th2 cytokines in mice with invasive aspergillosis.The role of complement in invasive fungal infections.In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.The use of caspofungin in HIV-infected individuals.Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France.Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatusA 52-year-old HIV-positive man with abdominal pain.Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis.Primary aspergilloma and subacute invasive aspergillosis in two AIDS patients.Emergence of invasive cerebral aspergillosis in an HIV-positive patient on voriconazole therapy.Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases.Aspergillosis among people infected with human immunodeficiency virus: incidence and survival. Adult and Adolescent Spectrum of HIV Disease Project.The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital.Diagnosis of aspergilloma in a pleural cavity (persistent pneumothorax) using classic imaging methods.
P2860
Q24683790-15CF8C4E-603F-4399-BE17-053186B5D955Q28078679-9F59A8ED-F904-4E7F-AABA-BCA53533EE74Q28344464-0FC931D9-EA87-4DDF-822B-4E6549F49DFAQ28345150-672DF031-221C-455C-A2FD-38F2061F7584Q28368930-76BD7335-41EB-4472-84DD-7B330C15BD3CQ28379300-A9B0630B-3AB4-4D6D-8C88-CE361ECB7B7CQ33662384-707C18BD-10B4-4174-AB1E-FB59092AC24AQ33697679-83A4E49B-50FE-45F5-84BF-F38FDE326FDEQ33978287-BBFC1556-BDCC-4CFE-95D0-A090A85B1DABQ33982075-0ABFFD8A-0667-4B41-9093-38DF6AC34E21Q34106775-D4C67AED-A287-4DCF-88BC-E5C87A22C323Q34154790-D6BD2D17-54A8-4DC2-B182-AEE4C81A24B3Q35567104-FDEC52BE-1076-4C9C-A682-45F8CA63C7F3Q35743823-1BE11EC7-1B6B-43B4-BBB3-F12755B04D95Q35870651-5C0A1C14-0952-4C95-A424-3119B15980EAQ36821383-C289E248-773F-491C-91A5-B1E2D92B6CA0Q36884359-AEDC59A2-1D33-40A8-AEE8-0C1E041AD54FQ38540401-E8A9B4DF-0270-4753-9C01-AA39FDD167A7Q39784524-7280DC43-2A47-4716-884C-3785E4DCF63FQ40271046-A9929E8D-4BEF-4154-8580-C7A4FAB1F80BQ40348802-69D787AE-30DB-42D7-8425-0761AFF1A97FQ43610568-6C5F1638-4823-4264-AE52-7C77BB03F606Q44495088-D218ADA4-35C7-457C-BD79-CFAAB0C80E3DQ45015455-AC5C3481-400F-4C7F-AE1B-1942FB2D082DQ45739769-45D54B93-25E8-4D82-AB05-FD74B90F1685Q46333475-6006A735-9EFB-47AB-935B-ADF4DBCFA89EQ53539461-D0344A1E-667F-4B54-9529-C63AE13DA75C
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Invasive aspergillosis in patients with AIDS.
@en
Invasive aspergillosis in patients with AIDS.
@nl
type
label
Invasive aspergillosis in patients with AIDS.
@en
Invasive aspergillosis in patients with AIDS.
@nl
prefLabel
Invasive aspergillosis in patients with AIDS.
@en
Invasive aspergillosis in patients with AIDS.
@nl
P921
P1476
Invasive aspergillosis in patients with AIDS.
@en
P2093
P356
10.1093/CLINIDS/19.SUPPLEMENT_1.S41
P407
P478
19 Suppl 1
P577
1994-08-01T00:00:00Z